Evaluation of trefoil factor 3 as a non-invasive biomarker of gastric intestinal metaplasia and gastric cancer in a high-risk population-Reference-Cited by-同舟云学术

Evaluation of trefoil factor 3 as a non-invasive biomarker of gastric intestinal metaplasia and gastric cancer in a high-risk population

Published:2023-06 Issue:6 Volume:46 Page:411-418
ISSN:2444-3824
Container-title:Gastroenterología y Hepatología (English Edition)
language:en
Short-container-title:Gastroenterología y Hepatología (English Edition)

Author:

Latorre Gonzalo,Pizarro Margarita,Ford James Stephen,Gándara Vicente,Muñoz Gonzalo,Araya Juan Carlos,Bellolio Enrique,Villaseca Miguel,Fuentes-López Eduardo,Cortés Pablo,Rollán Antonio,Bufadel María Ester,Araya Raúl,Vargas José Ignacio,Espino Alberto,Sharp Allan,Agüero Carlos,Donoso Andrés,Bresky Gustavo,Pedrero Pamela,Rueda Carlos,Calvo Alfonso,Odagaki Tomoyuki,Moriyama Tomohiko,Ishida Tsukasa,Parra-Blanco Adolfo,Camargo M. Constanza,González Robinson,Corvalán Alejandro H.,Riquelme Arnoldo

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference30 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancer in 185 countries;Sung;CA Cancer J Clin,2021

2. A model for gastric cancer epidemiology;Correa;Lancet,1975

3. A human model of gastric carcinogenesis;Correa;Cancer Res,1988

4. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands;de Vries;Gastroenterology,2008

5. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019